SCHEMBL6534119

SCHEMBL6534119

COCCCNC(=O)c1cc(-c2csc(C(=O)O)n2)n(CCc2ccc(OC)c(OC)c2)c1C

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.46
CYP3A4 P08684 1/20 0.46
ALDH1A1 P00352 7/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
MAPT P10636 4/20 0.44
LMNA P02545 3/20 0.44
HPGD P15428 2/20 0.44
HTT P42858 2/20 0.44
HSD17B10 Q99714 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
POLB P06746 3/20 0.43
NAMPT P43490 2/20 0.41
TP53 P04637 2/20 0.41
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5047164 0.92 POLB (0.49) TDP1CYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL5132459 0.86 POLB (0.44) TDP1CYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL5043726 0.79 SMN1; SMN2 (0.53) TDP1CYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL5048626 0.78 LMNA (0.41) ALDH1A1SMN1; SMN2MAPTLMNAHPGD
SCHEMBL5046847 0.77 ALDH1A1 (0.49) CYP3A4ALDH1A1MAPTLMNAHPGD
SCHEMBL5039641 0.76 ALDH1A1 (0.52) TDP1ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL5043612 0.73 PPARD (0.47) ALDH1A1SMN1; SMN2MAPTLMNAHTT
SCHEMBL5045966 0.72 KLKB1 (0.49) CYP3A4ALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL5047122 0.72 KLKB1 (0.46) CYP3A4ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL5048647 0.72 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2MAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-A1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-12 EP claimed
WO-2004060888-A1 NOVEL CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-22 WO claimed